Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Variable Density Magnetization Transfer (vdMT) imaging for 7 T MR Imaging.
Vitamin D status in patients with MS is negatively correlated with depression, but not with fatigue.
Dynamic pattern of clinical and MRI findings in a tumefactive demyelinating lesion: A case report.
Hypoxia-like tissue injury and glial response contribute to Balo concentric lesion development.
Vascularized nerve grafts: an experimental study.
Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine.
Induction of gut regulatory CD39(+) T cells by teriflunomide protects against EAE.
Behavioral and electromyographic assessment of oxaliplatin-induced motor dysfunctions: evidence for a therapeutic effect of allopregnanolone.
Distinctive characteristics of early-onset and late-onset neuromyelitis optica spectrum disorders.
Identification of the Kappa-Opioid Receptor as a Therapeutic Target for Oligodendrocyte Remyelination.
Safety and efficacy of dimethyl fumarate in multiple sclerosis: a multi-center observational study.
A Diet Mimicking Fasting Promotes Regeneration and Reduces Autoimmunity and Multiple Sclerosis Symptoms.
Measurement properties of the Arm Function in Multiple Sclerosis Questionnaire (AMSQ): a study based on Classical Test Theory.
Immunotherapy Improves Cognitive Function in Secondary Progressive Multiple Sclerosis.
Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: design and lessons from a 16-year observational study.
Metabolic profiling reveals biochemical pathways and potential biomarkers associated with the pathogenesis of Krabbe disease.
Transfer of myelin-specific cells deviated in vitro towards IL-4 production ameliorates ongoing experimental allergic neuritis.
Peculiarities of Neurological Disorders and Study Designs.
Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon β-1a in MS.
Regional disparities in botulinum toxin A (BoNT-A) therapy for spasticity in Sweden: budgetary consequences of closing the estimated treatment gap.
Regional differences in interhemispheric structural fibers in healthy, term infants.
Injectable Disease Modifying Agents in Multiple Sclerosis: Pattern of Medication Use and Clinical Effectiveness.
Resolvin D1 Programs Inflammation Resolution by Increasing TGF-β Expression Induced by Dying Cell Clearance in Experimental Autoimmune Neuritis.
The relationship between sleep quality and perceived fatigue measured using the Neurological Fatigue Index in people with Multiple Sclerosis.
Long-term follow-up on a patient with incomplete POEMS syndrome undergoing high-dose therapy and autologous blood stem cell transplantation.

Pages